X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Dr. Reddys with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ADCOCK INGRAM (S. Africa) - Comparison Results

DR. REDDYS LAB    Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   ADCOCK INGRAM
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-18
ADCOCK INGRAM
Jun-14
DR. REDDYS LAB/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,788357-   
Low Rs1,902258-   
Sales per share (Unadj.) Rs860.8106.3-  
Earnings per share (Unadj.) Rs57.1-26.8-  
Cash flow per share (Unadj.) Rs122.0-22.2-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs757.783.5-  
Shares outstanding (eoy) m165.91168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.72.9 94.2%   
Avg P/E ratio x41.1-11.5 -357.8%  
P/CF ratio (eoy) x19.2-13.9 -138.7%  
Price / Book Value ratio x3.13.7 83.9%  
Dividend payout %35.00-   
Avg Mkt Cap Rs m389,03451,922 749.3%   
No. of employees `00023.54.3 548.0%   
Total wages/salary Rs m32,1493,259 986.5%   
Avg. sales/employee Rs Th6,070.84,180.1 145.2%   
Avg. wages/employee Rs Th1,366.6759.1 180.0%   
Avg. net profit/employee Rs Th402.5-1,053.3 -38.2%   
INCOME DATA
Net Sales Rs m142,81017,945 795.8%  
Other income Rs m1,552126 1,235.0%   
Total revenues Rs m144,36218,071 798.9%   
Gross profit Rs m23,512-3,110 -756.1%  
Depreciation Rs m10,772775 1,390.8%   
Interest Rs m788486 162.1%   
Profit before tax Rs m13,504-4,245 -318.1%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m3440-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,380265 1,651.4%   
Profit after tax Rs m9,468-4,522 -209.4%  
Gross profit margin %16.5-17.3 -95.0%  
Effective tax rate %32.4-6.2 -519.1%   
Net profit margin %6.6-25.2 -26.3%  
BALANCE SHEET DATA
Current assets Rs m104,98413,143 798.8%   
Current liabilities Rs m68,9387,395 932.2%   
Net working cap to sales %25.232.0 78.8%  
Current ratio x1.51.8 85.7%  
Inventory Days Days74111 67.0%  
Debtors Days Days104124 83.6%  
Net fixed assets Rs m104,3857,661 1,362.5%   
Share capital Rs m83083 996.2%   
"Free" reserves Rs m124,8860-   
Net worth Rs m125,71614,085 892.6%   
Long term debt Rs m25,0894,950 506.9%   
Total assets Rs m225,44326,608 847.3%  
Interest coverage x18.1-7.7 -234.6%   
Debt to equity ratio x0.20.4 56.8%  
Sales to assets ratio x0.60.7 93.9%   
Return on assets %4.5-15.2 -30.0%  
Return on equity %7.5-32.1 -23.5%  
Return on capital %9.7-19.8 -49.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m53,7070-   
CASH FLOW
From Operations Rs m18,0301,532 1,177.1%  
From Investments Rs m-14,883-470 3,164.4%  
From Financial Activity Rs m-4,4404,492 -98.8%  
Net Cashflow Rs m-1,2365,554 -22.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.93 Rs / ZAR

Compare DR. REDDYS LAB With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: DR. DATSONS LABS  SUVEN LIFESCIENCES  ORCHID PHARMA LTD  VENUS REMEDIES  BIOCON   



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views On News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Apr 18, 2019 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS